Massachusetts Financial Services’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-8,866
Closed -$2.35M 872
2017
Q3
$2.35M Sell
8,866
-14,919
-63% -$4.31M ﹤0.01% 694
2017
Q2
$6.27M Sell
23,785
-4,575
-16% -$1.15M ﹤0.01% 660
2017
Q1
$10.2M Sell
28,360
-5,113
-15% -$1.58M ﹤0.01% 587
2016
Q4
$9.66M Sell
33,473
-3,226
-9% -$1,000K ﹤0.01% 594
2016
Q3
$12.5M Buy
36,699
+1,336
+4% +$488K 0.01% 546
2016
Q2
$15M Sell
35,363
-2,184
-6% -$900K 0.01% 530
2016
Q1
$12M Sell
37,547
-155
-0.4% -$52.9K 0.01% 557
2015
Q4
$19.5M Sell
37,702
-12,336
-25% -$4.55M 0.01% 504
2015
Q3
$14.7M Sell
50,038
-4,912
-9% -$1.75M 0.01% 547
2015
Q2
$21.6M Sell
54,950
-2,067
-4% -$729K 0.01% 508
2015
Q1
$17.2M Sell
57,017
-7,813
-12% -$1.91M 0.01% 561
2014
Q4
$14.4M Sell
64,830
-31,288
-33% -$6.45M 0.01% 582
2014
Q3
$22.3M Sell
96,118
-2,191
-2% -$552K 0.01% 506
2014
Q2
$21.7M Buy
98,309
+10,753
+12% +$2.39M 0.01% 517
2014
Q1
$27.6M Buy
+87,556
New +$27.9M 0.02% 450

Other funds holding TXMD

Massachusetts Financial Services's TXMD Position: Q4 2017 in Review

Massachusetts Financial Services sold out of TherapeuticsMD (TXMD) in Q4 2017, closing a stake of 8,866 shares — an estimated $2.35M sold.

Massachusetts Financial Services first reported a position in TXMD in Q1 2014 and held it in 15 quarters. The position peaked at $27.6M in Q1 2014. 144 funds tracked by Wall St. Rank hold TXMD as of Q4 2017.

  • Massachusetts Financial Services reported no remaining TherapeuticsMD position as of Q4 2017 after selling out during the quarter.
  • Massachusetts Financial Services sold 8,866 TherapeuticsMD shares in Q4 2017, an estimated $2.35M.
  • Massachusetts Financial Services first reported a position in TherapeuticsMD in Q1 2014 and held it in 15 quarters.
  • Massachusetts Financial Services's TherapeuticsMD position peaked at $27.6M in Q1 2014.
  • 144 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2017.

Based on Massachusetts Financial Services's 13F filing for Q4 2017, filed 14 Feb 2018.